News & events
Q-linea signs distribution partnership for Benelux
Interim report 1 January - 30 September 2023
Dialogue with the FDA intensifies
Third quarter: 1 July–30 September 2023
• Net sales amounted to SEK 3.0 million (2.9).
• The operating result...
Read more >
Invitation to presentation of Q-linea’s Interim report Q3-2023 on November 2, 2023
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company’s Interim report for the period January – September 2023...
Read more >
Q-linea strengthens its presence in Finland and the Baltics through partnership with Labema Oy
Q-linea AB (Publ) (OMX: QLINEA) today announces that the company has entered into an agreement with Labema Oy for...
Read more >
Strong ASTar results presented at IBMS
Q-linea receives second ASTar order in France
Q-linea AB (publ) (OMX: QLINEA) today announces that the company has received a second order for an ASTar instrument...
Read more >
ECCMID 2024
NSCMID 2023
Load more